These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Outcomes after heart transplantation in patients who have undergone a bridge-to-bridge strategy. Zhou AL; Etchill EW; Shou BL; Whitbread JJ; Barbur I; Giuliano KA; Kilic A JTCVS Open; 2022 Dec; 12():255-268. PubMed ID: 36590736 [TBL] [Abstract][Full Text] [Related]
25. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study. Sauren LD; Accord RE; Hamzeh K; de Jong M; van der Nagel T; van der Veen FH; Maessen JG Artif Organs; 2007 Nov; 31(11):839-42. PubMed ID: 18001394 [TBL] [Abstract][Full Text] [Related]
26. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). Dangas GD; Kini AS; Sharma SK; Henriques JP; Claessen BE; Dixon SR; Massaro JM; Palacios I; Popma JJ; Ohman M; Stone GW; O'Neill WW Am J Cardiol; 2014 Jan; 113(2):222-8. PubMed ID: 24527505 [TBL] [Abstract][Full Text] [Related]
27. Impella Support Versus Intra-Aortic Balloon Pump in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Meta-Analysis. Moustafa A; Khan MS; Saad M; Siddiqui S; Eltahawy E Cardiovasc Revasc Med; 2022 Jan; 34():25-31. PubMed ID: 33549497 [TBL] [Abstract][Full Text] [Related]
28. Prolonged waitlisting is associated with mortality in extracorporeal membrane oxygenation-supported heart transplantation candidates. Nordan T; Critsinelis AC; Vest A; Zhang Y; Chen FY; Couper GS; Kawabori M JTCVS Open; 2022 Dec; 12():234-254. PubMed ID: 36590718 [TBL] [Abstract][Full Text] [Related]
29. Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support. Han J; Moayedi Y; Yang W; Henricksen EJ; Lee R; Purewal S; Chang E; Duclos S; Lyapin A; Feng K; Hiesinger W; Teuteberg JJ; Khush KK J Heart Lung Transplant; 2022 Feb; 41(2):237-243. PubMed ID: 34815161 [TBL] [Abstract][Full Text] [Related]
30. Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock. Haberkorn S; Uwarow A; Haurand J; Jung C; Kelm M; Westenfeld R; Horn P Open Heart; 2020 Nov; 7(2):. PubMed ID: 33132209 [TBL] [Abstract][Full Text] [Related]
31. Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra aortic blood pump and IMPELLA Recover LP2.5. Manzo-Silberman S; Fichet J; Mathonnet A; Varenne O; Ricome S; Chaib A; Zuber B; Spaulding C; Cariou A Resuscitation; 2013 May; 84(5):609-15. PubMed ID: 23069592 [TBL] [Abstract][Full Text] [Related]
32. IABP versus Impella Support in Cardiogenic Shock: "In Silico" Study. De Lazzari B; Capoccia M; Badagliacca R; Bozkurt S; De Lazzari C J Cardiovasc Dev Dis; 2023 Mar; 10(4):. PubMed ID: 37103019 [TBL] [Abstract][Full Text] [Related]
33. The New Era of Cardiogenic Shock: Progress in Mechanical Circulatory Support. Seliem A; Hall SA Curr Heart Fail Rep; 2020 Dec; 17(6):325-332. PubMed ID: 32936410 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of Renal Function in Cardiogenic Shock Patients With or Without Mechanical Circulatory Support. Upadhyaya VD; Alshami A; Patel I; Douedi S; Quinlan A; Thomas T; Prentice J; Calderon D; Asif A; Sen S; Mehra A; Hossain MA J Clin Med Res; 2021 May; 13(5):283-292. PubMed ID: 34104280 [TBL] [Abstract][Full Text] [Related]
35. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. O'Neill WW; Kleiman NS; Moses J; Henriques JP; Dixon S; Massaro J; Palacios I; Maini B; Mulukutla S; Dzavík V; Popma J; Douglas PS; Ohman M Circulation; 2012 Oct; 126(14):1717-27. PubMed ID: 22935569 [TBL] [Abstract][Full Text] [Related]
36. Impella 5.5 Support Beyond 50 Days as Bridge to Heart Transplant in End-Stage Heart Failure Patients. Zaky M; Nordan T; Kapur NK; Vest AR; DeNofrio D; Chen FY; Couper GS; Kawabori M ASAIO J; 2023 Apr; 69(4):e158-e162. PubMed ID: 35947797 [TBL] [Abstract][Full Text] [Related]
37. UNOS listing status-related changes in mechanical circulatory support utilization and outcomes in adult congenital heart disease patients. Zhou AL; Menachem JN; Danford DA; Kutty S; Cedars AM J Heart Lung Transplant; 2022 Jul; 41(7):889-895. PubMed ID: 35397877 [TBL] [Abstract][Full Text] [Related]
38. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients. Schäfer A; Werner N; Burkhoff D; Sieweke JT; Zietzer A; Masyuk M; Junker Udesen NL; Westenfeld R; Møller JE Front Cardiovasc Med; 2020; 7():74. PubMed ID: 32478095 [No Abstract] [Full Text] [Related]
39. The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience. Pieri M; Contri R; Winterton D; Montorfano M; Colombo A; Zangrillo A; De Bonis M; Pappalardo F BMC Cardiovasc Disord; 2015 Oct; 15():126. PubMed ID: 26466899 [TBL] [Abstract][Full Text] [Related]